⬆️ IFX levels associated with better outcomes in fistulizing CD: ✔️ Higher W14 IFX levels associated with W14 fistula response and W54 remission ✔️ W2 ≥20.2 μg/mL, W6 ≥15 μg/mL, and W14 ≥7.2 μg/mL associated with W14 composite remission #AIBD2024 Miguel Regueiro @IBDConference

Hey IBD Followers! For those of you who've enjoyed my IBD Tweetorials, I've started a new IBD education project that I hope you enjoy as well It's called TL;DR IBD (for the olds, that's short for Too Long, Didn't Read IBD), where I provide succinct capsule summaries of the

Seven (!) ustekunumab bio similar approved for IBD. David T. Rubin, MD GUILD Conference

Check out our recently published review on positioning therapies and treatment selection in ulcerative colitis! David T. Rubin, MD UChicagoIBD Journal of the Canadian Assn of Gastroenterology academic.oup.com/jcag/article/8…

Concerns have been raised about a possible link between GLP-1 RAs and suicidality. Our latest study published in the The BMJ provides reassuring findings. Great work by my doctoral student Samantha Shapiro and team! bmj.com/content/388/bm…

Is consent for recording / publishing needed? How to 🎥 excellent video and when to submit? 📨 Join us and find all answers tonight! Steven Bollipo Keith Siau Enrique de-Madaria Mohammad Bilal, MD Dalbir Sandhu, MD, FACG, FASGE Jan Král Russell Yanofsky

Poor form to attack 👩‍⚕️ Laura T 👩‍⚕️ JK Rowling. We should all be standing up for the rights of the trans community. There is no better advocate and role model than Laura. I stand with her.

Paradigm-shifting finding: Seton placement not associated with improved outcomes with anti-TNF therapy for perianal fistulas. If reproduced in prospective studies, this could fundamentally change our current understanding and clinical practice in managing these challenging

Tremfya is FDA approved for Crohn's disease! This has both IV (200 mg) and subq (400 mg) induction loading dose options followed by subq maintenance dose (100 mg or 200 mg). #GITwitter #IBD jnj.com/media-center/p…

Appreciate the opportunity to be part of this case and learn from Amelia Kellar, Sarah Stein, and David T. Rubin, MD about the intersection of Hermansky-Pudlak Syndrome, Crohn’s, and HS. Check out our case report here!

Thrilled to have launched the Intestinal Ultrasound (IUS) service in Prince of Wales Hospital, Hong Kong and joined IBUS InternationalBowelUS as module 2 training center! Thank you Noa Krugliak Cleveland, MD and Amelia Kellar for the untiring guidance throughout the 6 months in UChicago! #ibd

Ready to present our hard work on real-world experience of UPADACITINIB reinduction and high dose maintenance therapy to recapture disease response in inflammatory bowel disease! #DDW2025 UChicagoIBD

Introducing Gabe Yanofsky, the newest and youngest member of the David T. Rubin, MD research team! Amelia Kellar Noa Krugliak Cleveland, MD @Klein_Jeremy David Choi, PharmD Asher Shafrir

The Crohn's and Colitis Foundation's Take Steps Walk is only 1 week away on June 8th! If you can't join us in person, please consider donating to our team, Intestinal Fortitude. Every dollar counts! Crohn's & Colitis Foundation UChicagoIBD takesteps.crohnscolitisfoundation.org/participants/5…

The potential impact of this RCT is huge. First one to prove that exercise has benefits equal to many standard treatments for cancer. Wow! Congrats to #ChrisBooth, #KerryCourneya eg al. Go Canada! nejm.org/doi/full/10.10…

Our new meta-analysis in the Journal of IBD demonstrated that IBD was associated with EoE, independent of IBD subtype. Thanks to Parul Tandon DO PhD FRCPC for the mentorship and support throughout and the team for this great collaboration! Alexa N Sasson, MD Tarun Chhibba academic.oup.com/ibdjournal/adv…

Grateful to be a part of this important work defining ultrasound parameters for measuring bowel damage in Crohn’s Disease: The EXTENT Study: sciencedirect.com/science/articl… Cathy Lu Bram Verstockt Rune Wilkens Mariangela Allocca Noa Krugliak Cleveland, MD Michael Todd Dolinger, MD MBA Florian Rieder Joana Torres